Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs CORAL LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH CORAL LAB. PANACEA BIOTECH/
CORAL LAB.
 
P/E (TTM) x -72.3 15.0 - View Chart
P/BV x 1.0 0.9 118.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   CORAL LAB.
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
CORAL LAB.
Mar-23
PANACEA BIOTECH/
CORAL LAB.
5-Yr Chart
Click to enlarge
High Rs191368 52.0%   
Low Rs107217 49.4%   
Sales per share (Unadj.) Rs75.1218.8 34.3%  
Earnings per share (Unadj.) Rs-5.518.1 -30.5%  
Cash flow per share (Unadj.) Rs0.924.2 3.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs137.7433.6 31.8%  
Shares outstanding (eoy) m61.253.57 1,715.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.3 148.6%   
Avg P/E ratio x-27.116.2 -167.1%  
P/CF ratio (eoy) x170.012.1 1,403.1%  
Price / Book Value ratio x1.10.7 160.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m9,1421,045 874.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1,265111 1,136.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,599781 588.8%  
Other income Rs m51769 749.3%   
Total revenues Rs m5,116850 601.8%   
Gross profit Rs m4739 122.1%  
Depreciation Rs m39122 1,794.6%   
Interest Rs m443 1,308.8%   
Profit before tax Rs m12882 155.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46618 2,613.7%   
Profit after tax Rs m-33764 -523.6%  
Gross profit margin %1.04.9 20.7%  
Effective tax rate %363.521.6 1,679.3%   
Net profit margin %-7.38.3 -88.9%  
BALANCE SHEET DATA
Current assets Rs m5,6231,235 455.2%   
Current liabilities Rs m3,297119 2,780.2%   
Net working cap to sales %50.6143.0 35.4%  
Current ratio x1.710.4 16.4%  
Inventory Days Days59231 25.4%  
Debtors Days Days481,094 4.4%  
Net fixed assets Rs m7,028508 1,383.4%   
Share capital Rs m6136 171.4%   
"Free" reserves Rs m8,3751,512 553.8%   
Net worth Rs m8,4361,548 545.0%   
Long term debt Rs m2020-   
Total assets Rs m12,7121,743 729.1%  
Interest coverage x3.925.3 15.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.4 80.8%   
Return on assets %-2.33.9 -59.3%  
Return on equity %-4.04.2 -96.1%  
Return on capital %2.05.5 36.1%  
Exports to sales %43.392.1 47.0%   
Imports to sales %24.40-   
Exports (fob) Rs m1,992719 277.0%   
Imports (cif) Rs m1,124NA-   
Fx inflow Rs m1,992719 277.0%   
Fx outflow Rs m1,19113 8,933.8%   
Net fx Rs m801706 113.5%   
CASH FLOW
From Operations Rs m-4,225127 -3,335.6%  
From Investments Rs m4,303-26 -16,456.3%  
From Financial Activity Rs m-184-64 285.9%  
Net Cashflow Rs m-10536 -289.7%  

Share Holding

Indian Promoters % 73.6 20.0 368.5%  
Foreign collaborators % 0.0 51.5 -  
Indian inst/Mut Fund % 1.1 0.1 792.9%  
FIIs % 0.3 0.1 192.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 28.5 92.7%  
Shareholders   46,242 4,098 1,128.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs CORAL LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs CORAL LAB. Share Price Performance

Period Panacea Biotech CORAL LAB. S&P BSE HEALTHCARE
1-Day -1.44% -0.17% 0.45%
1-Month 13.70% -0.97% 2.55%
1-Year 20.31% 48.65% 56.14%
3-Year CAGR -26.96% -3.40% 15.22%
5-Year CAGR -6.22% 2.89% 19.63%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the CORAL LAB. share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of CORAL LAB. the stake stands at 71.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of CORAL LAB..

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

CORAL LAB. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of CORAL LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.